Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Amicus Therapeutics, Inc. (FOLD)

« Back to company index

FOLD Chatter Timeline

Stock Ticker for FOLD

Most Active Tweeters for FOLD

UserTweets
@The_CasualSmart 9
@usindexlive 8
@MareaInformativ 8
@bibeypost_stock 7
@reurope_stock 7

Recent Tweets for FOLD

beyond_ninety @beyond_ninety
Emory University Upped Amicus Therapeutics $FOLD Stake; Greywolf Capital Management LP Trimmed By $2.38 Million Its… https://t.co/N2Qfp2lZsJ
August 20th 2018, 3:08pm
ConsumerFeed @ConsumerFeed
Amicus Therapeutics $FOLD Downgraded by Chardan Capital https://t.co/4TofHO8NPe
August 20th 2018, 5:08am
usindexlive @usindexlive
Amicus Therapeutics $FOLD Shareholder Artal Group Sa Has Lifted Holding by $16.50 Million as Stock Price Rose; Cond… https://t.co/a5PMSBnWSG
August 20th 2018, 5:08am
MareaInformativ @MareaInformativ
Zacks: Brokerages Anticipate Amicus Therapeutics, Inc. $FOLD Will Announce Earnings of -$0.33 Per Share https://t.co/7juoPS8nsJ
August 19th 2018, 11:08pm
TheMarketsDaily @TheMarketsDaily
Amicus Therapeutics $FOLD Cut to Neutral at Chardan Capital https://t.co/YK3cyvZDam
August 19th 2018, 11:08am
usindexlive @usindexlive
Hudson Bay Capital Management LP Holds Holding in Amicus Therapeutics $FOLD; Neumeier Poma Investment Counsel Conti… https://t.co/twyJdERL2a
August 19th 2018, 11:08am
WatchlistN @WatchlistN
BidaskClub Lowers Amicus Therapeutics $FOLD to Strong Sell https://t.co/qfolsklXvg
August 19th 2018, 9:08am
bibeypost_stock @bibeypost_stock
Amicus Therapeutics, Inc. $FOLD's Stock Formed A Several Months Wedge Down - https://t.co/mkupcV7nU6
August 19th 2018, 9:08am
mmahotstuff1 @mmahotstuff1
What Will Happen to Amicus Therapeutics, Inc. $FOLD Next? The Stock Formed a Several Months Wedge Down Chart Patter… https://t.co/gFPNayX2RS
August 19th 2018, 9:08am
reurope_stock @reurope_stock
Amicus Therapeutics, Inc. $FOLD's Bearish Wedge Down Pattern Points to Higher Stock Risks https://t.co/QySLr8aFU5
August 19th 2018, 9:08am
west_moreland @west_moreland
Does Amicus Therapeutics, Inc. $FOLD Have Any Gas After Forming This Bearish Wedge Down? https://t.co/aoYyiK9cWu
August 19th 2018, 9:08am
Fanob_stock @Fanob_stock
What's Next for Amicus Therapeutics, Inc. $FOLD After Forming Bearish Wedge Down Chart Pattern? https://t.co/6IIqpiraru
August 19th 2018, 9:08am
pennyomegaCRWE @pennyomegaCRWE
Analysts' Viewpoints - $FOLD, $NTNX https://t.co/xI0i1AFOOZ https://t.co/AzGLFhqDyT
August 19th 2018, 9:08am
ThisLincolnian @ThisLincolnian
Zacks: Brokerages Anticipate Amicus Therapeutics, Inc. $FOLD Will Announce Earnings of -$0.27 Per Share https://t.co/t5RZURvjZa
August 18th 2018, 11:08pm
OlympiaReport @OlympiaReport
$23.31 Million in Sales Expected for Amicus Therapeutics, Inc. $FOLD This Quarter https://t.co/YSDgmEGaLR
August 18th 2018, 11:08pm
WeekHerald @WeekHerald
Zacks: Analysts Expect Amicus Therapeutics, Inc. $FOLD Will Announce Earnings of -$0.27 Per Share https://t.co/2xVxPYBwOs
August 18th 2018, 11:08pm
MareaInformativ @MareaInformativ
$23.31 Million in Sales Expected for Amicus Therapeutics, Inc. $FOLD This Quarter https://t.co/xqKGkHyyRu
August 18th 2018, 11:08pm
EnterpriseLeade @EnterpriseLeade
Amicus Therapeutics $FOLD Rating Increased to Strong-Buy at ValuEngine https://t.co/8gLAPQXIZD
August 18th 2018, 6:08pm
tgtxdough @tgtxdough
$FOLD catalysts: • 3Q18. AT-GAA: Type C meeting with FDA on Pompe disease program • 10 October 2018. Gene therapy:… https://t.co/NUqEKttgN0
August 18th 2018, 6:08pm
beyond_ninety @beyond_ninety
Sectoral Asset Management Upped Amicus Therapeutics $FOLD Position; Vaxart $VXRT Sellers Decreased By 61.75% Their… https://t.co/MJ2E7STZ9U
August 18th 2018, 12:08pm
dakotafinancial @dakotafinancial
Amicus Therapeutics $FOLD Downgraded to Strong Sell at BidaskClub https://t.co/cAK2y88LAt
August 18th 2018, 7:08am
AmericanBanking @AmericanBanking
Amicus Therapeutics, Inc. $FOLD Given Consensus Rating of “Buy” by Analysts https://t.co/GLEktGkVIu #stocks
August 18th 2018, 4:08am
ConsumerFeed @ConsumerFeed
Amicus Therapeutics, Inc. $FOLD Receives Average Recommendation of “Buy” from Brokerages https://t.co/6QHEmbVJ1c
August 18th 2018, 4:08am
IlliniJJ @IlliniJJ
$FOLD most analysts have agendas, but this is an interesting take. could be sour grapes from not being involved in… https://t.co/lX5qpTj4ZR
August 17th 2018, 1:08pm
AmericanBanking @AmericanBanking
Amicus Therapeutics $FOLD Stock Rating Lowered by Chardan Capital https://t.co/5JQ6nqF7Sv #stocks
August 17th 2018, 12:08pm
bibeypost_stock @bibeypost_stock
Shares of Amicus Therapeutics $FOLD Struck With Downgrade From Chardan Capital. Should Investors be Concerned? - https://t.co/LYYAsnfful
August 17th 2018, 10:08am
mmahotstuff1 @mmahotstuff1
The Rating of Amicus Therapeutics $FOLD Shares By Chardan Capital Falls. $15 is now The Target Price per Share - https://t.co/Ez7mhJaZNJ
August 17th 2018, 10:08am
QuantchaIdeas @QuantchaIdeas
Covered Call Alert: AMICUS THERAPEUTICS $FOLD returning up to 30.21% through 18-Jan-2019 https://t.co/jshg136rId https://t.co/76Yx76rVFT
August 17th 2018, 10:08am
whatsonthorold2 @whatsonthorold2
Should Investors Consider Selling Amicus Therapeutics $FOLD Shares Now That Chardan Capital Downgraded The Company?… https://t.co/53vBUbZHve
August 17th 2018, 10:08am
reurope_stock @reurope_stock
Will Today’s Chardan Capital Downgrade Ultimately Hurt The Stock Price of Amicus Therapeutics $FOLD? https://t.co/Ff9Sgv4av5
August 17th 2018, 10:08am
west_moreland @west_moreland
Is it Now Time For Investors to Consider Selling Amicus Therapeutics $FOLD Stock? Chardan Capital Downgrades The Co… https://t.co/0F0d1EzXUb
August 17th 2018, 10:08am
Fanob_stock @Fanob_stock
Has Chardan Capital Lost Faith in Amicus Therapeutics $FOLD After Recent Downgrade https://t.co/cOJruWnjJI
August 17th 2018, 10:08am
bibeypost_stock @bibeypost_stock
Is Amicus Therapeutics $FOLD Really Worth Your Time and Dime After a Downgrade Today By Chardan Capital - https://t.co/mJouTnWJLz
August 17th 2018, 10:08am
mmahotstuff1 @mmahotstuff1
Just How Negative is Chardan Capital on Amicus Therapeutics $FOLD Following Its Downgrade? The Target Price is $15 - https://t.co/55xYNYt3ZS
August 17th 2018, 10:08am
reurope_stock @reurope_stock
Is Amicus Therapeutics $FOLD Really Worth Your Time and Dime After a Downgrade Today By Chardan Capital https://t.co/MTW4UEAghM
August 17th 2018, 10:08am
whatsonthorold2 @whatsonthorold2
Will Today’s Chardan Capital Downgrade Ultimately Hurt The Stock Price of Amicus Therapeutics $FOLD? - https://t.co/tZVBEfCzou
August 17th 2018, 10:08am
west_moreland @west_moreland
The Rating of Amicus Therapeutics $FOLD Shares By Chardan Capital Falls. $15 is now The Target Price per Share https://t.co/oOjypPktaD
August 17th 2018, 10:08am
The_CasualSmart @The_CasualSmart
Does a Chardan Capital Downgrade Make Shares of Amicus Therapeutics $FOLD a Sell? https://t.co/7JwFH6HEf1
August 17th 2018, 10:08am
BioWino @BioWino
downgrading because the stock hasn't gotten taken out yet. F'ing moronic thought process there. Chardan $fold.
August 17th 2018, 10:08am
Fanob_stock @Fanob_stock
Chardan Capital Decides to Give Amicus Therapeutics $FOLD a Lower Rating. The Target is Now $15 https://t.co/RufyQf2r7q
August 17th 2018, 10:08am
BioWino @BioWino
$fold "US approval follows the recent successful Japan launch and strong Galafold adoption globally. Despite these… https://t.co/NtwujcEZyC
August 17th 2018, 10:08am
JSTOCKBROKERS @JSTOCKBROKERS
RT @BioStocks: $FOLD downgraded from Buy to Neutral at Chardan. PT $15
August 17th 2018, 9:08am
bibeypost_stock @bibeypost_stock
Chardan Capital Markets Has Downgraded Shares of Amicus Therapeutics $FOLD Giving it a $15 Target Price per Share - https://t.co/GcRugTPkG4
August 17th 2018, 9:08am
bibeypost_stock @bibeypost_stock
Chardan Capital Markets: Downgrade Hits Shares of Amicus Therapeutics $FOLD - https://t.co/eTHo4ci21j
August 17th 2018, 9:08am
reurope_stock @reurope_stock
The Rating of Amicus Therapeutics $FOLD Shares By Chardan Capital Markets Falls. $15 is now The Target https://t.co/TK4XW9Evx7
August 17th 2018, 9:08am
reurope_stock @reurope_stock
Should Investors Be Selling Amicus Therapeutics $FOLD Shares? Chardan Capital Markets Downgrades Stock https://t.co/QUWTCV7n8R
August 17th 2018, 9:08am
The_CasualSmart @The_CasualSmart
Chardan Capital Markets Has Cut Rating on Amicus Therapeutics $FOLD To a "Neutral". The TP is Set to $15 https://t.co/wI0eeKawZ4
August 17th 2018, 9:08am
The_CasualSmart @The_CasualSmart
Amicus Therapeutics $FOLD Has Just Been Downgraded by Chardan Capital Markets to a "Neutral" Rating https://t.co/OgeXE7FB77
August 17th 2018, 9:08am
The_CasualSmart @The_CasualSmart
Chardan Capital Markets Has Downgraded Shares of Amicus Therapeutics $FOLD Giving it a $15 Target https://t.co/ZGl07pCFkc
August 17th 2018, 9:08am
The_CasualSmart @The_CasualSmart
Amicus Therapeutics $FOLD Receives a Lower Rating From Chardan Capital Markets. Will Other Analysts Follow Suit? https://t.co/5WYEVxnj8k
August 17th 2018, 9:08am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2018. All rights reserved.